Circulating fibrocytes as prognostic biomarkers of autoimmune interstitial lung disease.
John OdackalVictor YuDiana Gomez-ManjerresJoshua J FieldMarie D BurdickBorna MehradPublished in: ERJ open research (2020)
In patients with autoimmune interstitial lung disease, circulating fibrocytes may represent a biomarker of outcome and treatment response.